Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dvora Shmulewitz

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Addiction (Abingdon, England)|August 18, 2022
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCPOfir Livne, Dvora Shmulewitz, Claire Walsh, et al.
Drug and Alcohol Dependence|October 27, 2018
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adultsOfir Livne, Dvora Shmulewitz, Shaul Lev-Ran, et al.
Substance Abuse Treatment, Prevention, and Policy|October 12, 2023
Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from IsraelDvora Shmulewitz, Roi Eliashar, Maor Daniel Levitin, et al.
The International Journal on Drug Policy|September 29, 2021
Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011June H Kim, Silvia S Martins, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence|November 11, 2021
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adultsSarah Gutkind, David S Fink, Dvora Shmulewitz, et al.
Addictive Behaviors Reports|September 19, 2022
Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019Claire A Walsh, Ofir Livne, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence|August 27, 2021
Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance usersOfir Livne, Dvora Shmulewitz, Malka Stohl, et al.
Alcoholism, Clinical and Experimental Research|September 28, 2021
Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5Zachary L Mannes, Dvora Shmulewitz, Ofir Livne, et al.
JAMA Psychiatry|October 11, 2023
Use of Lysergic Acid Diethylamide by Major Depression StatusClaire A Walsh, Lauren Gorfinkel, Dvora Shmulewitz, et al.
European Addiction Research|July 10, 2026
Using Machine Learning with the Brief Symptom Inventory to Screen for Comorbid Addictions: A Proof-of-Principle StudyMaor Daniel Levitin, Dvora Shmulewitz, Roi Eliashar, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Addiction (Abingdon, England)|August 18, 2022
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCPOfir Livne, Dvora Shmulewitz, Claire Walsh, et al.
Drug and Alcohol Dependence|October 27, 2018
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adultsOfir Livne, Dvora Shmulewitz, Shaul Lev-Ran, et al.
Substance Abuse Treatment, Prevention, and Policy|October 12, 2023
Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from IsraelDvora Shmulewitz, Roi Eliashar, Maor Daniel Levitin, et al.
The International Journal on Drug Policy|September 29, 2021
Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011June H Kim, Silvia S Martins, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence|November 11, 2021
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adultsSarah Gutkind, David S Fink, Dvora Shmulewitz, et al.
Addictive Behaviors Reports|September 19, 2022
Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019Claire A Walsh, Ofir Livne, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence|August 27, 2021
Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance usersOfir Livne, Dvora Shmulewitz, Malka Stohl, et al.
Alcoholism, Clinical and Experimental Research|September 28, 2021
Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5Zachary L Mannes, Dvora Shmulewitz, Ofir Livne, et al.
JAMA Psychiatry|October 11, 2023
Use of Lysergic Acid Diethylamide by Major Depression StatusClaire A Walsh, Lauren Gorfinkel, Dvora Shmulewitz, et al.
European Addiction Research|July 10, 2026
Using Machine Learning with the Brief Symptom Inventory to Screen for Comorbid Addictions: A Proof-of-Principle StudyMaor Daniel Levitin, Dvora Shmulewitz, Roi Eliashar, et al.
Pageof 8